-
Experts say the new drug edaravone, an oral form of Radicava, will make it easier for people with ALS because it doesn't require an IV tube
-
-
The Ness Rewards app allows users to earn points for actions such as going to the gym or getting regular checkups. They can then redeem earned points for deals with a growing list of partner brands.
-
Researchers say the cancer drug imatinib helped people with severe COVID-19 cases recover more quickly and shorten their hospital stays
-
The Biden administration's revamped Cancer Moonshot initiative includes more federal agencies and more programs to advance cancer research
-
Some patients who have taken Pfizer Inc.’s oral antiviral Paxlovid are reporting that their COVID-19 symptoms returned after initially improving when they completed treatment. We talked to experts about why that may be occuring.
-
The Olympic gold medalist shares how therapy helped him learn to accept his depression and anxiety, setting him on the right path to improve his mental health.
-
One million Americans have died since the start of pandemic and an estimated 9 million Americans have lost a family member to COVID. Public health experts predict that 1.1 million people could die by the end of 2022 — but that will largely depend on the behavior of new variants and the durability of our immunity against COVID.
-
Experts say chronic pain can cause mental health issues. In addition, they say, those mental health issues can worsen chronic pain.
-
Experts say the need for booster shots is growing in importance as the number of COVID-19 deaths among vaccinated people rises